Note for guidance. Production and quality control of cytokine products derived by biotechnological processes. Committee for Proprietary Medicinal Products: Ad hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
D001709:Biotechnology; D002461:Cell Line, Transformed; D016207:Cytokines / Q000096:biosynthesis / Q000302:isolation & purification / Q000592:standards*; D005062:European Union; D005818:Genetic Engineering; D011786:Quality Control; D012015:Reference Standards
D016207:Cytokines